Delivery Order SPE2DB22D3004-SPE2DB25FQE67

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LISDEXAMFETAMINE 10 MG CAPSULE 100S. The contract has a ceiling value of $3,939.48 and a completion date of May 13, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 60 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,198.62 and a completion date of May 13, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp also holds a...
This federal contract award, valued at $1,301.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567394902 - LISDEXAMFETAMINE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LISDEXAMFETAMINE 30 MG CAPSULE 100S, with a ceiling value of $1,062.38 and a completion date of May 20, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.51 firm-fixed-price delivery order is for the supply of 4566802887 LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S. This is a firm fixed-price delivery order contract with a performance period through March 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,684.12, is for the delivery of 4567501343 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LISDEXAMFETAMINE 10 MG CAPSULE 100S. The Delivery Order is valued at $3,487.05 and has a performance period through March 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LISDEXAMFETAMINE 60 MG CAPSULE 100S. The contract has a firm fixed price of $1,139.42 and a performance period ending on May 23, 2025. The award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,274.55, is a Firm Fixed Price Delivery Order for the supply of 4567533906 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQE67
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S, a medication, with a ceiling value of $4,933.06. The contract is a Delivery Order and has a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of April 9, 2025.

Generated 7/8/25, 2:36 PM